COVID-19 may bring high risks of severe disease and death in many patients by disrupting key metabolic signals and thereby triggering hyperglycemia, according to a new study from researchers at Weill Cornell Medicine and NewYork-Presbyterian.
from News Medical Medical Research News Feed https://ift.tt/3l3URYD https://ift.tt/eA8V8J